Open AccessClinical applications of intravascular magnetic resonance contrast agents
Author(s) -
Essig M.
Publication year - 2008
Publication title -
imaging decisions mri
Language(s) - English
Resource type - Journals
eISSN - 1617-0830
pISSN - 1433-3317
DOI - 10.1111/j.1617-0830.2007.00108.x
Subject(s) - medicine , contrast (vision) , magnetic resonance imaging , radiology , image contrast , image enhancement , nuclear medicine , artificial intelligence , computer science , image (mathematics)
Summary Gadofosveset Trisodium (Vasovist) is a safe and well tolerated intravascular contrast agent, currently approved in Europe and Canada. It has proved to be effective in the asessment of vascular diseases at all vascular territories. The possibility to image at steady state opens new horizons by increasing the spatial resolution and the robustness of diagnostic MRA. Initial studies proved the possibility to image beyond the vascular territory and to assess enhancing lesions as known from studies with standard contrast agents.